Vaxigrip Tetra

Vaxigrip Tetra Description

vaccine, influenza

Manufacturer:

sanofi pasteur

Distributor:

DKSH
Full Prescribing Info
Description
Influenza virus (inactivated, split) of the following strains*: A/Victoria/4897/2022 (H1N1)pdm09 - like strain (A/Victoria/4897/2022, IVR-238) 15 micrograms HA**; A/Darwin/9/2021 (H3N2) - like strain (A/Darwin/9/2021, IVR-228) 15 micrograms HA**; B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type) 15 micrograms HA**; B/Phuket/3073/2013 - like strain (B/Phuket/3073/2013, wild type) 15 micrograms HA**.
For one 0.5 mL dose.
* propagated in fertilised hens' eggs from healthy chicken flocks.
** haemagglutinin.
This vaccine complies with the WHO recommendations (Northern Hemisphere) for the 2023/2024 season.
VaxigripTetra may contain traces of eggs, such as ovalbumin, and of neomycin, formaldehyde and octoxinol-9, which are used during the manufacturing process (see Contraindications).
Excipients/Inactive Ingredients: Buffer Solution: Sodium chloride, Potassium chloride, Disodium phosphate dihydrate, Potassium dihydrogen phosphate, Water for injections.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in